CARBACHOL Drug Patent Profile
✉ Email this page to a colleague
When do Carbachol patents expire, and when can generic versions of Carbachol launch?
Carbachol is a drug marketed by Pharmafair and is included in one NDA.
The generic ingredient in CARBACHOL is carbachol. There is one drug master file entry for this compound. One supplier is listed for this compound. Additional details are available on the carbachol profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for CARBACHOL?
- What are the global sales for CARBACHOL?
- What is Average Wholesale Price for CARBACHOL?
Summary for CARBACHOL
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 70 |
Clinical Trials: | 7 |
Patent Applications: | 4,539 |
DailyMed Link: | CARBACHOL at DailyMed |
Recent Clinical Trials for CARBACHOL
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Visus Therapeutics | Phase 3 |
Visus Therapeutics | Phase 2 |
Hannover Medical School |
Medical Subject Heading (MeSH) Categories for CARBACHOL
Anatomical Therapeutic Chemical (ATC) Classes for CARBACHOL
US Patents and Regulatory Information for CARBACHOL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pharmafair | CARBACHOL | carbachol | SOLUTION;INTRAOCULAR | 070292-001 | May 21, 1986 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |